Irreversible Electroporation(IRE) For Unresectable Hilus Pulmonis Neoplasms
Condition(s):Hilus Pulmonary NeoplasmsLast Updated:September 5, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Hilus Pulmonary NeoplasmsLast Updated:September 5, 2021Completed
Condition(s):Uterine Cervical NeoplasmsLast Updated:September 5, 2021Completed
Condition(s):Renal Pelvic and Ureteral NeoplasmsLast Updated:September 5, 2021Completed
Condition(s):Lymph Node MetastasesLast Updated:September 5, 2021Completed
Condition(s):Lung Neoplasms Accompanied by Respiratory Function InsufficiencyLast Updated:September 5, 2021Completed
Condition(s):Renal TumorLast Updated:September 5, 2021Completed
Condition(s):Laryngeal NeoplasmsLast Updated:September 5, 2021Completed
Condition(s):Liver CancerLast Updated:September 5, 2021Completed
Condition(s):Refractory Paroxysmal Atrial FibrillationLast Updated:March 28, 2024Active, not recruiting
Condition(s):Pancreatic CancerLast Updated:February 26, 2020Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.